Our series highlighting recent activity by the NYS Legislature continues with a recap of bills passed in 2018 that relate to behavioral health. This synopsis follows previous summaries we have done concerning pharmacy (here), hospitals (here), long term care and aging (here).
Except where otherwise noted, these bills await action by the Governor.
Mental
Continue Reading Legislation Affecting Behavioral Health
The latest installation in our series on legislation recently passed by the New York State Legislature (introduced here) addresses legislation in the long term care and aging space. It follows upon descriptions of legislation in the pharmacy space (here) and hospital space (here). Like those areas, the long term care area was impacted by
Continue Reading Legislation Affecting Long Term Care & Aging
During a year in which legislative activity was restrained by a variety of factors, most notably the Senate’s inability to maintain a consistent majority, the New York State Legislature nonetheless still passed 641 bills, several of which would affect the pharmaceutical sector. While the Governor has until the end of the year to consider and act on these proposals, we
Continue Reading Legislation Affecting the Pharmaceutical Industry
The scheduled 2018 New York State Legislative Session concluded last week amid many of the same speculations and controversies that have characterized all of the Legislature’s activities in recent years. Once again, much of the activity turned on the Legislature’s tense relationship with the Governor, ongoing questions about control of the Senate, and a backdrop of corruption trials that continue
Continue Reading Healthcare Bills Passed in the 2018 Legislative Session
As we reported in our annual series highlighting the various healthcare related provisions of the 2018-19 New York State Budget (here), the Enacted Budget reflects the state’s overall policy towards consolidation of the home care marketplace. Nowhere is the effort to force consolidation more apparent than in the Licensed
Continue Reading DOH Issues Additional Guidance on New LHCSA Moratorium and other Restrictions Imposed by the 2018-19 Enacted New York State Budget.
With so much happening in the cannabis industry we thought we’d take this time to highlight some of the industry’s most recent happenings.
This, the last of our posts on the 2018-19 New York State Health Budget (the “Enacted Budget”), focuses on an area of healthcare that has perhaps the broadest impact of the sector as a whole — managed care. A prior post in the series (
Continue Reading The Broadest Impact: 2018-19 New York State Managed Care Budget Highlights
There are probably few in the healthcare community in New York State who would disagree that, among provider types, hospitals have typically received the most attention from policymakers. The hospitals themselves might argue the point, or point out that having the attention of policymakers is
Continue Reading Small Issues with Big Impacts: 2018-19 New York State Hospital Budget Highlights
Since the beginning of the administration of Governor Andrew Cuomo, there has been a strong emphasis on reform of the acute, primary, and long term care systems, and, particularly with the recent focus on the opioid crisis, that attention has extended to the behavioral
Continue Reading A Renewed Focus: 2018-19 New York State Intellectual and Developmental Disabilities Budget Highlights
Several provisions in the recently adopted 2018-19 New York State Budget (the “Enacted Budget”) are intended to address the ongoing opioid crisis. As discussed in a prior post (here), some were focused on pharmaceutical manufacturers. Some of the most significant provisions